ILMN Illumina Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ILMN

Price (delayed)

$212.22

Market cap

$33.38B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$26.43

Enterprise value

$34.87B

Illumina, Inc. is an American company. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a ...

Highlights
Illumina's revenue has increased by 10% YoY
The company's gross profit rose by 5% YoY
The quick ratio has plunged by 69% YoY and by 7% from the previous quarter
The equity has decreased by 36% YoY and by 36% from the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.illumina.com
Peers: PKI PACB A TMO

Key stats

What are the main financial stats of ILMN
Market
Shares outstanding
157.3M
Market cap
$33.38B
Enterprise value
$34.87B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.96
Price to sales (P/S)
7.09
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.42
Earnings
Revenue
$4.7B
EBIT
-$4.05B
EBITDA
-$3.68B
Free cash flow
$259M
Per share
EPS
-$26.43
Free cash flow per share
$1.65
Book value per share
$42.79
Revenue per share
$29.93
TBVPS
$29.83
Balance sheet
Total assets
$11.26B
Total liabilities
$4.53B
Debt
$2.49B
Equity
$6.73B
Working capital
-$182M
Liquidity
Debt to equity
0.37
Current ratio
0.93
Quick ratio
0.63
Net debt/EBITDA
-0.41
Margins
EBITDA margin
-78.2%
Gross margin
66.3%
Net margin
-88.4%
Operating margin
-85.4%
Efficiency
Return on assets
-29%
Return on equity
-42.8%
Return on invested capital
-97.7%
Return on capital employed
-47.2%
Return on sales
-86.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ILMN stock price

How has the Illumina stock price performed over time
Intraday
-0.85%
1 week
-1.92%
1 month
4.96%
1 year
-36.07%
YTD
4.96%
QTD
4.96%

Financial performance

How have Illumina's revenue and profit performed over time
Revenue
$4.7B
Gross profit
$3.12B
Operating income
-$4.01B
Net income
-$4.15B
Gross margin
66.3%
Net margin
-88.4%
Illumina's revenue has increased by 10% YoY
The company's gross profit rose by 5% YoY
The gross margin has contracted by 4.3% YoY

Growth

What is Illumina's growth rate over time

Valuation

What is Illumina stock price valuation
P/E
N/A
P/B
4.96
P/S
7.09
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.42
The price to book (P/B) is 48% lower than the 5-year quarterly average of 9.7 but 11% higher than the last 4 quarters average of 4.5
The equity has decreased by 36% YoY and by 36% from the previous quarter
ILMN's P/S is 46% below its 5-year quarterly average of 13.3 and 24% below its last 4 quarters average of 9.4
Illumina's revenue has increased by 10% YoY

Efficiency

How efficient is Illumina business performance

Dividends

What is ILMN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ILMN.

Financial health

How did Illumina financials performed over time
The total assets is 149% more than the total liabilities
The quick ratio has plunged by 69% YoY and by 7% from the previous quarter
The current ratio has plunged by 65% YoY and by 7% from the previous quarter
Illumina's debt is 63% lower than its equity
The debt to equity has soared by 61% year-on-year and by 54% since the previous quarter
The equity has decreased by 36% YoY and by 36% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.